Shilong Fu

466 total citations
20 papers, 350 citations indexed

About

Shilong Fu is a scholar working on Cancer Research, Molecular Biology and Oncology. According to data from OpenAlex, Shilong Fu has authored 20 papers receiving a total of 350 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Cancer Research, 10 papers in Molecular Biology and 5 papers in Oncology. Recurrent topics in Shilong Fu's work include Cancer-related molecular mechanisms research (8 papers), Circular RNAs in diseases (7 papers) and MicroRNA in disease regulation (6 papers). Shilong Fu is often cited by papers focused on Cancer-related molecular mechanisms research (8 papers), Circular RNAs in diseases (7 papers) and MicroRNA in disease regulation (6 papers). Shilong Fu collaborates with scholars based in China and Australia. Shilong Fu's co-authors include Suping Han, Meilin Wang, Bo Ding, Wei Sun, Zhengdong Zhang, Wei Wang, Wei Sun, Wenjun Cheng, Xiuli Wang and Xiaofeng Song and has published in prestigious journals such as Gene, Cancer Letters and Gynecologic Oncology.

In The Last Decade

Shilong Fu

20 papers receiving 346 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shilong Fu China 12 217 207 60 56 56 20 350
Jinxiao Liang China 10 100 0.5× 218 1.1× 49 0.8× 83 1.5× 39 0.7× 27 330
Chunfang Ha China 9 117 0.5× 160 0.8× 64 1.1× 76 1.4× 49 0.9× 25 308
Jayne Maidens Australia 5 214 1.0× 217 1.0× 30 0.5× 97 1.7× 23 0.4× 5 387
Kanwal Minhas Canada 8 135 0.6× 209 1.0× 38 0.6× 56 1.0× 78 1.4× 13 344
Michael Jewer Canada 7 78 0.4× 187 0.9× 44 0.7× 64 1.1× 58 1.0× 8 309
Mitsuyo Yoshida Japan 12 108 0.5× 167 0.8× 36 0.6× 121 2.2× 92 1.6× 20 354
Moito Iijima Japan 8 81 0.4× 152 0.7× 70 1.2× 78 1.4× 42 0.8× 18 315
Herta Bettendorf Germany 12 68 0.3× 217 1.0× 55 0.9× 92 1.6× 84 1.5× 15 387
Bangdong Liu China 7 125 0.6× 172 0.8× 32 0.5× 35 0.6× 43 0.8× 10 261
Haruko Kunitomi Japan 9 112 0.5× 183 0.9× 22 0.4× 71 1.3× 16 0.3× 17 311

Countries citing papers authored by Shilong Fu

Since Specialization
Citations

This map shows the geographic impact of Shilong Fu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shilong Fu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shilong Fu more than expected).

Fields of papers citing papers by Shilong Fu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shilong Fu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shilong Fu. The network helps show where Shilong Fu may publish in the future.

Co-authorship network of co-authors of Shilong Fu

This figure shows the co-authorship network connecting the top 25 collaborators of Shilong Fu. A scholar is included among the top collaborators of Shilong Fu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shilong Fu. Shilong Fu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Xing, et al.. (2023). Feasibility of Sentinel Lymph Node Mapping With Carbon Nanoparticles in Cervical Cancer: A Retrospective Study. Cancer Control. 30. 2915613764–2915613764. 3 indexed citations
2.
Sun, Wei, Hang Dong, Suping Han, et al.. (2022). Construction of circRNA-associated ceRNA network reveals the regulation of fibroblast proliferation in cervical cancer. Gene. 844. 146824–146824. 6 indexed citations
3.
Cao, Ying, et al.. (2021). SNX10 and PTGDS are associated with the progression and prognosis of cervical squamous cell carcinoma. BMC Cancer. 21(1). 694–694. 20 indexed citations
4.
Chen, Chen, Yali Chen, Wei Sun, et al.. (2021). LncCCLM inhibits lymphatic metastasis of cervical cancer by promoting STAU1-mediated IGF-1 mRNA degradation. Cancer Letters. 518. 169–179. 20 indexed citations
5.
Zhao, Jian, et al.. (2021). The circular RNA expression profile in ovarian serous cystadenocarcinoma reveals a complex circRNA–miRNA regulatory network. BMC Medical Genomics. 14(S2). 276–276. 2 indexed citations
6.
Mei, Yong, et al.. (2020). Identification of miRNA-mRNA Regulatory Network and Construction of Prognostic Signature in Cervical Cancer. DNA and Cell Biology. 39(6). 1023–1040. 11 indexed citations
7.
Sun, Wei, et al.. (2020). Identification of a metabolism-related gene expression prognostic model in endometrial carcinoma patients. BMC Cancer. 20(1). 864–864. 20 indexed citations
8.
Xu, Tianyi, et al.. (2020). Genome-Wide Analysis of the Expression of Circular RNA Full-Length Transcripts and Construction of the circRNA-miRNA-mRNA Network in Cervical Cancer. Frontiers in Cell and Developmental Biology. 8. 603516–603516. 23 indexed citations
9.
Xu, Yetao, Xi Xia, Ying Jiang, et al.. (2020). Down‐regulated lncRNA AGAP2‐AS1 contributes to pre‐eclampsia as a competing endogenous RNA for JDP2 by impairing trophoblastic phenotype. Journal of Cellular and Molecular Medicine. 24(8). 4557–4568. 28 indexed citations
10.
Sun, Wei & Shilong Fu. (2019). Role of cancer-associated fibroblasts in tumor structure, composition and the microenvironment in ovarian cancer (Review). Oncology Letters. 18(3). 2173–2178. 23 indexed citations
11.
Shi, Li, Shulin Zhou, Yi Jiang, et al.. (2014). [Gynecological malignant tumor related multiple primary malignant neoplasms: clinical analysis of 30 cases].. PubMed. 49(3). 199–203. 2 indexed citations
12.
Fu, Shilong, et al.. (2014). Preclinical humanized mouse model with ectopic ovarian tissues. Experimental and Therapeutic Medicine. 8(3). 742–746. 7 indexed citations
13.
Fu, Shilong, Lihua Dong, Wei Sun, et al.. (2013). Stromal–Epithelial Crosstalk Provides a Suitable Microenvironment for the Progression of Ovarian Cancer Cellsin Vitro. Cancer Investigation. 31(9). 616–624. 8 indexed citations
14.
Ding, Bo, Shilong Fu, Meilin Wang, et al.. (2011). Tumor Necrosis Factor α -308 G>A Polymorphisms and Cervical Cancer Risk. International Journal of Gynecological Cancer. 22(2). 213–219. 18 indexed citations
15.
Wang, Meilin, Bo Ding, Wei Wang, et al.. (2011). Polymorphism of the pre-miR-146a is associated with risk of cervical cancer in a Chinese population. Gynecologic Oncology. 122(1). 33–37. 88 indexed citations
16.
Ni, Jing, Meilin Wang, Miaomiao Wang, et al.. (2010). CCND1 G870A polymorphism and cervical cancer risk: a case–control study and meta-analysis. Journal of Cancer Research and Clinical Oncology. 137(3). 489–494. 16 indexed citations
17.
Han, Suping, et al.. (2009). Ectopic, autologous eutopic and normal endometrial stromal cells have altered expression and chemotactic activity of RANTES. European Journal of Obstetrics & Gynecology and Reproductive Biology. 143(1). 55–60. 9 indexed citations
18.
19.
20.
Li, Ziting & Shilong Fu. (2003). [Epithelial ovarian carcinoma metastatic to the brain: report on ten cases with review of literature].. PubMed. 38(5). 287–9. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jinxiao Liang Breakdown of academic impact, for papers by Chunfang Ha Breakdown of academic impact, for papers by Jayne Maidens Breakdown of academic impact, for papers by Kanwal Minhas Breakdown of academic impact, for papers by Michael Jewer Breakdown of academic impact, for papers by Mitsuyo Yoshida Breakdown of academic impact, for papers by Moito Iijima Breakdown of academic impact, for papers by Herta Bettendorf Breakdown of academic impact, for papers by Bangdong Liu Breakdown of academic impact, for papers by Haruko Kunitomi
Rankless by CCL
2026